For the quarter ending 2025-12-31, AEMD has $8,057,128 in assets. $1,344,031 in debts. $6,956,397 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Deferred offering cost | - | - | 9,103 | |
| Cash and cash equivalents | 6,956,397 | 5,853,493 | 3,765,154 | |
| Australian research and development tax incentive receivable | - | 218,314 | - | |
| Prepaid expenses and other current assets | 185,122 | 182,072 | 276,601 | |
| Total current assets | 7,141,519 | 6,253,879 | 4,050,858 | |
| Property and equipment, net | 434,179 | 513,992 | 593,720 | |
| Operating lease right-of-use asset, net | 382,583 | 456,496 | 529,576 | |
| Patents, net | 138 | 275 | 413 | |
| Restricted cash | 98,709 | 98,448 | 98,130 | |
| Deposits | 0 | 0 | 33,305 | |
| Total assets | 8,057,128 | 7,323,090 | 5,306,002 | |
| Accounts payable | 469,452 | 570,792 | 571,495 | |
| Due to related parties | 237,846 | 248,454 | 372,598 | |
| Operating lease liability, current portion | 330,628 | 324,656 | 318,800 | |
| Other current liabilities | 219,211 | 261,095 | 364,544 | |
| Total current liabilities | 1,257,137 | 1,404,997 | 1,627,437 | |
| Operating lease liability, less current portion | 86,894 | 172,116 | 255,052 | |
| Total liabilities | 1,344,031 | 1,577,113 | 1,882,489 | |
| Common stock, par value 0.001 per share 6,000,000 shares authorized as of december 31, 2025 and march 31, 2025 973,213 shares issued and outstanding as of december 31, 2025 and 258,531 shares issued and 201,074 outstanding at march 31, 2025 | 973 | 761 | 2,599 | |
| Additional paid-in capital | 179,963,981 | 176,975,368 | 173,159,966 | |
| Accumulated other comprehensive loss | -29,837 | -26,377 | -22,377 | |
| Accumulated deficit | -173,222,020 | -171,203,775 | -169,716,675 | |
| Total stockholders equity | 6,713,097 | 5,745,977 | 3,423,513 | |
| Total liabilities and stockholders equity | 8,057,128 | 7,323,090 | 5,306,002 | |
AETHLON MEDICAL INC (AEMD)
AETHLON MEDICAL INC (AEMD)